Skip to main content
SpringerLink
Log in

Late Stent Evaluation (Neoatherosclerosis)

  • Chapter
  • First Online:
Coronary Imaging and Physiology

  • 1864 Accesses

Abstract

Using light instead of ultrasound, optical coherence tomography (OCT) can provide high-resolution in vivo images of the coronary artery and evaluate the stent status and neointimal tissue after coronary stent implantation more accurately than intravascular ultrasound (IVUS). Intravascular OCT assessment is useful for the detection of strut coverage, malapposition, and the characterization of neointimal tissue during stent follow-up due to high resolution. Furthermore, OCT enables detailed assessment of the morphological characteristics of late stent failure, including neoatherosclerosis. In this chapter, late stent-based changes evaluated by OCT will be reviewed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease: Benestent Study Group. N Engl J Med. 1994;331:489–95.

    Article  CAS  PubMed  Google Scholar 

  2. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349(14):1315–23.

    Article  CAS  PubMed  Google Scholar 

  3. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350(3):221–31.

    Article  CAS  PubMed  Google Scholar 

  4. Farb A, Burke AP, Kolodgie FD, Virmani R. Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation. 2003;108(14):1701–6.

    Article  PubMed  Google Scholar 

  5. Forrester JS, Fishbein M, Helfant R, Fagin J. A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies. J Am Coll Cardiol. 1991;17(3):758–69.

    Article  CAS  PubMed  Google Scholar 

  6. Virmani R, Farb A. Pathology of in-stent restenosis. Curr Opin Lipidol. 1999;10(6):499–506.

    Article  CAS  PubMed  Google Scholar 

  7. Guagliumi G, Sirbu V, Bezerra H, Biondi-Zoccai G, Fiocca L, Musumeci G, et al. Strut coverage and vessel wall response to zotarolimus-eluting and bare-metal stents implanted in patients with ST-segment elevation myocardial infarction: the OCTAMI (optical coherence tomography in acute myocardial infarction) Study. JACC Cardiovasc Interv. 2010;3(6):680–7.

    Article  PubMed  Google Scholar 

  8. Guagliumi G, Musumeci G, Sirbu V, Bezerra HG, Suzuki N, Fiocca L, et al. Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents. JACC Cardiovasc Interv. 2010;3(5):531–9.

    Article  PubMed  Google Scholar 

  9. Guagliumi G, Costa MA, Sirbu V, Musumeci G, Bezerra HG, Suzuki N, et al. Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the harmonizing outcomes with revascularization and stents in acute myocardial infarction (HORIZONS-AMI) Trial. Circulation. 2011;123(3):274–81.

    Article  CAS  PubMed  Google Scholar 

  10. Xie Y, Takano M, Murakami D, Yamamoto M, Okamatsu K, Inami S, et al. Comparison of neointimal coverage by optical coherence tomography of a sirolimus-eluting stent versus a bare-metal stent three months after implantation. Am J Cardiol. 2008;102(1):27–31.

    Article  CAS  PubMed  Google Scholar 

  11. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet. 2007;369(9562):667–78.

    Article  CAS  PubMed  Google Scholar 

  12. Jeremias A, Sylvia B, Bridges J, Kirtane AJ, Bigelow B, Pinto DS, et al. Stent thrombosis after successful sirolimus-eluting stent implantation. Circulation. 2004;109(16):1930–2.

    Article  PubMed  Google Scholar 

  13. de la Torre Hernández JM, Tejedor P, Camarero TG, Duran JM, Lee DH, Monedero J, et al. Early healing assessment with optical coherence tomography of everolimus-eluting stents with bioabsorbable polymer (synergy™) at 3 and 6 months after implantation. Catheter Cardiovasc Interv. 2016;88(3):E67–73.

    Article  PubMed  Google Scholar 

  14. Kim JS, Jang IK, Kim TH, Takano M, Kume T, Hur NW, et al. Optical coherence tomography evaluation of zotarolimus-eluting stents at 9-month follow-up: comparison with sirolimus-eluting stents. Heart. 2009;95(23):1907–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Kim JS, Kim TH, Fan C, Lee JM, Kim W, Ko YG, et al. Comparison of neointimal coverage of sirolimus-eluting stents and paclitaxel-eluting stents using optical coherence tomography at 9 months after implantation. Circ J. 2010;74(2):320–6.

    Article  PubMed  Google Scholar 

  16. Kim BK, Kim JS, Park J, Ko YG, Choi D, Jang Y, et al. Comparison of optical coherence tomographic assessment between first- and second-generation drug-eluting stents. Yonsei Med J. 2012;53(3):524–9.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Kim JS, Kim BK, Jang IK, Shin DH, Ko YG, Choi D, et al. comparison of neointimal coverage between zotarolimus-eluting stent and everolimus-eluting stent using optical coherence tomography (COVER OCT). Am Heart J. 2012;163(4):601–7.

    Article  PubMed  Google Scholar 

  18. Kim S, Kim JS, Shin DH, Kim BK, Ko YG, Choi D, et al. Comparison of early strut coverage between zotarolimus- and everolimus-eluting stents using optical coherence tomography. Am J Cardiol. 2013;111(1):1–5.

    Article  CAS  PubMed  Google Scholar 

  19. Kim BK, Hong MK, Shin DH, Kim JS, Ko YG, Choi D, et al. Optical coherence tomography analysis of strut coverage in biolimus- and sirolimus-eluting stents: 3-month and 12-month serial follow-up. Int J Cardiol. 2013;168(5):4617–23.

    Article  PubMed  Google Scholar 

  20. Kim BK, Ha J, Mintz GS, Kim JS, Shin DH, Ko YG, et al. Randomised comparison of strut coverage between Nobori biolimus-eluting and sirolimus-eluting stents: an optical coherence tomography analysis. EuroIntervention. 2014;9(12):1389–97.

    Article  PubMed  Google Scholar 

  21. Takahara M, Kitahara H, Nishi T, Miura K, Miyayama T, Sugimoto K, et al. Very early tissue coverage after drug-eluting stent implantation: an optical coherence tomography study. Int J Cardiovasc Imaging. 2016.; Sep 6. [Epub ahead of print]

    Google Scholar 

  22. Takano M, Inami S, Jang IK, Yamamoto M, Murakami D, Seimiya K, et al. Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation. Am J Cardiol. 2007;99(8):1033–8.

    Article  CAS  PubMed  Google Scholar 

  23. Watanabe M, Uemura S, Kita Y, Sugawara Y, Goryo Y, Ueda T, et al. Impact of branching angle on neointimal coverage of drug-eluting stents implanted in bifurcation lesions. Coron Artery Dis. 2016;27(8):682–9.

    Article  PubMed  Google Scholar 

  24. Kim JS, Jang IK, Fan C, Kim TH, Kim JS, Park SM, et al. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stentimplantation by optical coherence tomography: the ENDEAVOR OCT trial. JACC Cardiovasc Interv. 2009;2:1240–7.

    Article  PubMed  Google Scholar 

  25. Davlouros PA, Nikokiris G, Karantalis V, Mavronasiou E, Xanthopoulou I, Damelou A, et al. Neointimal coverage and stent strut apposition six months after implantation of a paclitaxel eluting stent in acute coronary syndromes: an optical coherence tomography study. Int J Cardiol. 2011;151(2):155–9.

    Article  PubMed  Google Scholar 

  26. Kim JS, Fan C, Choi D, Jang IK, Lee JM, Kim TH, et al. Different patterns of neointimal coverage between acute coronary syndrome and stable angina after various types of drug-eluting stents implantation; 9-month follow-up optical coherence tomography study. Int J Cardiol. 2011;146(3):341–6.

    Article  PubMed  Google Scholar 

  27. Räber L, Zanchin T, Baumgartner S, Taniwaki M, Kalesan B, Moschovitis A, et al. Differential healing response attributed to culprit lesions of patients with acute coronary syndromes and stable coronary artery after implantation of drug-eluting stents: an optical coherence tomography study. Int J Cardiol. 2014;173(2):259–67.

    Article  PubMed  Google Scholar 

  28. Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation. 2007;115(18):2435–41.

    Article  PubMed  Google Scholar 

  29. Guagliumi G, Sirbu V, Musumeci G, Gerber R, Biondi-Zoccai G, Ikejima H, et al. Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging. JACC Cardiovasc Interv. 2012;5(1):12–20.

    Article  PubMed  Google Scholar 

  30. Won H, Shin DH, Kim BK, Mintz GS, Kim JS, Ko YG, et al. Optical coherence tomography derived cut-off value of uncovered stent struts to predict adverse clinical outcomes after drug-eluting stent implantation. Int J Cardiovasc Imaging. 2013;29(6):1255–63.

    Article  PubMed  Google Scholar 

  31. Ha J, Kim BK, Kim JS, Shin DH, Ko YG, Choi D, et al. Assessing neointimal coverage after DES implantation by 3D OCT. JACC Cardiovasc Imaging. 2012;5(8):852–3.

    Article  PubMed  Google Scholar 

  32. Kim JS, Ha J, Kim BK, Shin DH, Ko YG, Choi D, et al. The relationship between post-stent strut apposition and follow-up strut coverage assessed by a contour plot optical coherence tomography analysis. JACC Cardiovasc Interv. 2014;7(6):641–51.

    Article  PubMed  Google Scholar 

  33. Farb A, Kolodgie FD, Hwang JY, Burke AP, Tefera K, Weber DK, et al. Extracellular matrix changes in stented human coronary arteries. Circulation. 2004;110(8):940–7.

    Article  CAS  PubMed  Google Scholar 

  34. Nakano M, Vorpahl M, Otsuka F, Taniwaki M, Yazdani SK, Finn AV, et al. Ex vivo assessment of vascular response to coronary stents by optical frequency domain imaging. JACC Cardiovasc Imaging. 2012;5(1):71–82.

    Article  PubMed  Google Scholar 

  35. Gonzalo N, Serruys PW, Okamura T, van Beusekom HM, Garcia-Garcia HM, van Soest G, et al. Optical coherence tomography patterns of stent restenosis. Am Heart J. 2009;158(2):284–93.

    Article  PubMed  Google Scholar 

  36. Kim JS, Hong MK, Shin DH, Kim BK, Ko YG, Choi D, et al. Quantitative and qualitative changes in DES-related neointimal tissue based on serial OCT. JACC Cardiovasc Imaging. 2012;5(11):1147–55.

    Article  PubMed  Google Scholar 

  37. Kim JS, Afari ME, Ha J, Tellez A, Milewski K, Conditt G, et al. Neointimal patterns obtained by optical coherence tomography correlate with specific histological components and neointimal proliferation in a swine model of restenosis. Eur Heart J Cardiovasc Imaging. 2014;15(3):292–8.

    Article  PubMed  Google Scholar 

  38. Malle C, Tada T, Steigerwald K, Ughi GJ, Schuster T, Nakano M, et al. Tissue characterization after drug-eluting stent implantation using optical coherence tomography. Arterioscler Thromb Vasc Biol. 2013;33(6):1376–83.

    Article  CAS  PubMed  Google Scholar 

  39. Lutter C, Mori H, Yahagi K, Ladich E, Joner M, Kutys R, et al. Histopathological differential diagnosis of optical coherence tomographic image interpretation after stenting. JACC Cardiovasc Imaging. 2016;9:2511.

    Google Scholar 

  40. Kim JS, Lee JH, Shin DH, Kim BK, Ko YG, Choi D, et al. Long-term outcomes of neointimal hyperplasia without neoatherosclerosis after drug-eluting stent implantation. JACC Cardiovasc Imaging. 2014;7(8):788–95.

    Article  PubMed  Google Scholar 

  41. Nakazawa G, Otsuka F, Nakano M, Vorpahl M, Yazdani SK, Ladich E, et al. The pathology of neoatherosclerosis in human coronary implants: bare-metal and drug-eluting stents. J Am Coll Cardiol. 2011;57:1314–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Otsuka F, Byrne RA, Yahagi K, Mori H, Ladich E, Fowler DR, et al. Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment. Eur Heart J. 2015;36:2147–59.

    Article  PubMed  Google Scholar 

  43. Takano M, Yamamoto M, Inami S, Murakami D, Ohba T, Seino Y, et al. Appearance of lipid-laden intima and neovascularization after implantation of bare-metal stents extended late-phase observation by intracoronary optical coherence tomography. J Am Coll Cardiol. 2009;55:26–32.

    Article  PubMed  Google Scholar 

  44. Habara M, Terashima M, Nasu K, Kaneda H, Inoue K, Ito T, et al. Difference of tissue characteristics between early and very late restenosis lesions after bare-metal stent implantation: an optical coherence tomography study. Circ Cardiovasc Interv. 2011;4:232–8.

    Article  PubMed  Google Scholar 

  45. Lee SY, Shin DH, Mintz GS, Kim JS, Kim BK, Ko YG, et al. Optical coherence tomography-based evaluation of in-stent neoatherosclerosis in lesions with more than 50% neointimal cross-sectional area stenosis. EuroIntervention. 2013;9:945–51.

    Article  PubMed  Google Scholar 

  46. Yonetsu T, Kim JS, Kato K, et al. Comparison of incidence and time course of neoatherosclerosis between bare metal stents and drug-eluting stents using optical coherence tomography. Am J Cardiol. 2012;110:933–9.

    Article  CAS  PubMed  Google Scholar 

  47. Lee SY, Hur SH, Lee SG, Kim SW, Shin DH, Kim JS, et al. Optical coherence tomographic observation of in-stent neoatherosclerosis in lesions with more than 50% neointimal area stenosis after second-generation drug-eluting stent implantation. Circ Cardiovasc Interv. 2015;8:e001878.

    Article  PubMed  Google Scholar 

  48. Nakamura D, Attizzani GF, Toma C, Sheth T, Wang W, Soud M, et al. Failure mechanisms and neoatherosclerosis patterns in very late drug-eluting and bare-metal stent thrombosis. Circ Cardiovasc Interv. 2016;9:e003785.

    Article  CAS  PubMed  Google Scholar 

  49. Kang SJ, Mintz GS, Akasaka T, Park DW, Lee JY, Kim WJ, et al. Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation. Circulation. 2011;123:2954–63.

    Article  CAS  PubMed  Google Scholar 

  50. Yonetsu T, Kato K, Kim SJ, Xing L, Jia H, McNulty I, et al. Predictors for neoatherosclerosis: a retrospective observational study from the optical coherence tomography registry. Circ Cardiovasc Imaging. 2012;5:660–6.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiology, Yeungnam University Medical Center, Yeungnam University College of Medicine, Daegu, South Korea

    Jung-Hee Lee

  2. Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, South Korea

    Yangsoo Jang & Jung-Sun Kim

Authors
  1. Jung-Hee Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yangsoo Jang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jung-Sun Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jung-Sun Kim .

Editor information

Editors and Affiliations

  1. Division of Cardiology, Severance Cardiovascular Hospital , Seoul, Korea (Republic of)

    Myeong-Ki Hong

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Singapore Pte Ltd.

About this chapter

Cite this chapter

Lee, JH., Jang, Y., Kim, JS. (2018). Late Stent Evaluation (Neoatherosclerosis). In: Hong, MK. (eds) Coronary Imaging and Physiology. Springer, Singapore. https://doi.org/10.1007/978-981-10-2787-1_17

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-2787-1_17

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-2786-4

  • Online ISBN: 978-981-10-2787-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation